Resource
HRSRW - Trastuzumab for HER2-positive breast cancer: a systematic review
A systematic review of the best available evidence on the use of trastuzumab (Herceptin®) in breast cancer.
| Filename | hrsrw-trastuzumab-for-her2-positive-breast-cancer-systematic-review.pdf |
| Filesize | 539.3 kB |
| Filetype | pdf (Mime Type: application/pdf) |
| Created On: | 01/07/2007 00:00 |
| Last updated on | 29/05/2009 05:43 |